If a client on a GLP-1 medicine seems to be eating very little, your job is to notice it, stay within any limits their provider has set and refer them to their prescriber or a registered dietitian, not to set a diet. A small English study published November 17, 2026 in the BMJ Nutrition, Prevention & Health paper found that 14 patients on these medicines, from one practice and with no comparison group, ate, on average, 58.5% of their estimated energy needs over two recorded days. Here’s what the study found, what it means for your sessions, and the questions to ask.
Disclosure: Plainly, several links on this page are affiliate links. When you purchase through them, this site may be paid a commission. This costs you nothing extra.

What did the study find?
StudyFinds reported the study on November 19, 2026. The outlet describes its format as AI-assisted with human editorial oversight, and its breakdown of the group is below. The 14 patients came from one general practice in England: 11 women and 3 men, aged 27 to 73. Ten paid privately and four used the NHS. Food logs ran from one to 10 days, and the main analysis used the first two days.
Quick facts, as of 2026-11-20:
| Item | What was reported |
|---|---|
| Study type | A small exploratory observational study, labeled a service evaluation, with patient feedback |
| Published | November 17, 2026, in BMJ Nutrition, Prevention & Health |
| Patients | 14 adults: 12 on Mounjaro and 2 on semaglutide (StudyFinds) |
| Average energy intake | 1,231 kcal a day, 58.5% of estimated needs (BMJ Group press release) |
| People recorded below 800 kcal a day in the study | 3 of 14 patients; StudyFinds reported the lowest as 541 kcal, for one person |
| Protein | Averaged 153% of the UK reference (BMJ Group press release) |
| Common shortfalls | Fiber and vitamin D below two-thirds of the UK reference for more than three quarters of patients; iron for about half (BMJ Group press release) |
| Patient reports | Reported by patients: little structured follow-up, some dizziness, and low blood pressure |
StudyFinds reported a lowest figure of 541 calories for one person, not an average. The group average was 1,231. In the BMJ Group press release, the authors say no drug-specific nutritional monitoring framework exists. The authors say it is observational, so no conclusions can be drawn about cause and effect, and that it covers a small group from one practice. It also had no comparison group, so it tells you what to watch for, not how common undereating is.
What did patients in the study report about eating?
Patients in the study reported less “food noise,” and some were surprised by how little they were eating. Some avoided social meals. The study could not show that the medicines caused any of this. The 2025 joint advisory on nutrition also lists gastrointestinal side effects among the challenges, so stomach effects are one more thing the advisory flags.
What the sources report, side by side:
| Source | What the sources report |
|---|---|
| 2025 joint advisory | The 2025 joint advisory says GLP-1s reduce weight 5-18% in trials |
| BMJ study, reported by patients | Patients in the BMJ Nutrition study described less “food noise” |
| BMJ study and 2025 joint advisory | Nutrient shortfalls, including fiber, vitamin D and iron in the BMJ study; the advisory lists nutrient deficiencies from calorie reduction |
| 2025 joint advisory | Muscle and bone loss, which the advisory lists as a challenge |
| BMJ study, reported by patients | Dizziness and low blood pressure, reported by patients in the BMJ study |
| 2025 joint advisory | Gastrointestinal effects, listed in the advisory |
What guidance says about eating and lifting?
The 2025 joint advisory comes from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society. It is expert consensus, not a trial. Its priorities include baseline screening, managing GI effects, preventing nutrient deficiencies, “preserving muscle and bone mass through resistance training and appropriate diet,” and registered dietitian counseling.
What can you do as a trainer, and what belongs to the prescriber?
MedlinePlus guide to working with a personal trainer sets the lines clearly. It says a trainer should not tell a client how to treat a medical condition, and should stay within any limits a provider has set. It also leaves specific nutrition advice to the client’s providers and dietitians.
| You can | You leave to the prescriber or a dietitian |
|---|---|
| Ask how the client is feeling and eating, in general terms | Diagnosing anything |
| Notice dizziness during sessions | Calorie or protein targets |
| Stay within any limits the client’s provider has set | Advice on doses, or on starting, stopping or switching |
| Ask the client or their provider about exercise limits | Specific nutritional advice |
| Encourage the client to raise it with their prescriber | Diet plans for a medical condition |
| Document what you see and, with the client’s consent, refer | Treatment decisions |
What did the T-REx lifting trial test?
The 2025 joint advisory lists preserving muscle through resistance training and appropriate diet among its priorities. A Nature research highlight dated November 20, 2026 reports that “Weightlifting can partially prevent the muscle loss caused by some obesity drugs.”
The trial behind that is the T-REx trial paper in Nature Medicine. It randomized 120 previously sedentary men and postmenopausal women aged 50 to 70 to tirzepatide alone, or to tirzepatide plus three supervised resistance sessions a week, for 40 weeks. The trial tested tirzepatide only, and it did not test undereating, so it says nothing about clients who eat very little. Weight loss was about the same in both groups (-22.61 kg and -22.28 kg). Total lean soft tissue loss was 1.09 kg smaller in the group that lifted (about 3.6 kg lost versus about 4.7 kg in the tirzepatide-only group). Strength fell in the tirzepatide-only group and rose in the lifting group. The trial recorded six serious adverse events, which the authors judged unrelated. Eli Lilly supplied the tirzepatide and reviewed the protocol and draft manuscript.
For more on how this plays out in training, see our page on personal trainers and clients on glp-1 medicines.
What can you notice without judging a client’s diet?
The study measured two days of food logs, not blood levels. In the study, patients reported dizziness and low blood pressure. In sessions, you can notice dizziness and what you observe or what a client tells you about how they’re eating, without judging their diet. Those are things the client can raise with their prescriber.
The study’s numbers are results, not targets for a client.
What questions can you ask your client?
Keep these general and conversational. They help you notice, and they give the prescriber something to act on.
- How are you feeling after sessions, and on the days in between?
- Do you get dizzy when you stand up, or during training?
- What does a normal day of eating look like for you right now?
- Is anyone helping you with your eating?
- Have you talked with your prescriber about how you feel and how you’re eating?
- Do you have a follow-up booked with your prescriber?
How do you write a referral note?
A short note keeps the handover clear. Share it only with the client’s consent, or give it to the client to carry to their prescriber. Fill in the brackets:
Client: [name]. Session date: [date]. [Client] reports [dizziness or feeling unwell after sessions] and describes their eating as [their words]. In this session I [what you changed]. I’ve encouraged [client] to raise these symptoms and their eating with their prescriber, and I’d suggest a referral to a registered dietitian. I’ll check in again on [date].
What should your client bring to the prescriber?
- Is what I’m eating enough for me?
- Can my dizziness and blood pressure be checked?
- Should I see a registered dietitian?
- How should resistance training fit with my treatment?
- Who follows up with me, and how often?
What are the common mix-ups?
| Common mix-up | What the sources say |
|---|---|
| “541 calories is what people on GLP-1s eat” | StudyFinds reported it as one person. The group averaged 1,231 kcal a day, 58.5% of estimated needs. |
| “Protein is the main gap” | Protein averaged above the UK reference in this group, but that says nothing about any one client. Fiber, vitamin D and iron were the common shortfalls. |
| “The 2025 advisory is a clinical trial” | It is expert consensus, not a trial. |
| “Lifting weights stops muscle loss” | In the T-REx trial, resistance training reduced lean mass loss by 1.09 kg. It partially reduced it; it did not stop it. |
How long does a client stay on it, and what happens when they stop?
Those are decisions for the prescriber. The 2025 joint advisory lists nutritional priorities for weight maintenance after stopping as an area that needs more study.
Your next step
Keep it small. At your next session, ask one question from the list above and write down the answer. If anything worries you, use the referral note and, with the client’s consent, share it with their prescriber, or give it to the client to carry. If you’re building the skills for this kind of client, how to become a personal trainer sets out the steps.
By the Fitness Career Guide Editorial Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.